[HTML][HTML] Current advances of artificial pancreas systems: a comprehensive review of the clinical evidence

SJ Moon, I Jung, CY Park - Diabetes & Metabolism Journal, 2021 - synapse.koreamed.org
Abstract Since Banting and Best isolated insulin in the 1920s, dramatic progress has been
made in the treatment of type 1 diabetes mellitus (T1DM). However, dose titration and timely …

In Silico Evaluation of the Medtronic 780G System While Using the GS3 and Its Calibration-Free Successor, the G4S Sensor

B Grosman, N Parikh, A Roy, L Lintereur… - Annals of Biomedical …, 2023 - Springer
In silico simulation studies using 5807 virtual patients with insulin dependent diabetes have
been conducted to estimate the risk and efficacy with the closed-loop 780G pump when …

[HTML][HTML] Performance of fast-acting aspart insulin as compared to aspart insulin in insulin pump for managing type 1 diabetes mellitus: A meta-analysis

D Dutta, R Mohindra, K Mahajan… - … & Metabolism Journal, 2023 - synapse.koreamed.org
Background No meta-analysis has analysed efficacy and safety of fast-acting aspart insulin
(FIAsp) with insulin pump in type 1 diabetes mellitus (T1DM). Methods Electronic databases …

Validation of the UVA Simulation Replay Methodology Using Clinical Data: Reproducing a Randomized Clinical Trial

MF Villa-Tamayo, P Colmegna… - Diabetes Technology & …, 2024 - liebertpub.com
Background: Computer simulators of human metabolism are powerful tools to design and
validate new diabetes treatments. However, these platforms are often limited in the diversity …

Biomaterials in Their Role in Creating New Approaches for the Delivery of Drugs, Proteins, Nucleic Acids, and Mammalian Cells in Safety Pharmacology

LR Brown - Drug Discovery and Evaluation: Safety and …, 2024 - Springer
The use of biomaterials to enable and enhance life-saving therapies in medicine has its
documented roots in the 1600s. Historically drugs were administered systemically for acute …

[HTML][HTML] The evolution of insulin administration in type 1 Diabetes

CT Pinnaro, MJ Tansey - Journal of diabetes mellitus, 2021 - ncbi.nlm.nih.gov
Insulin has been utilized in the treatment of type 1 diabetes (T1D) for 100 years. While there
is still no cure for T1D, insulin administration has undergone a remarkable evolution which …

Operational Safety in Human-in-the-loop Human-in-the-plant Autonomous Systems

A Banerjee, A Maity, I Lamrani, SKS Gupta - arXiv preprint arXiv …, 2024 - arxiv.org
Control affine assumptions, human inputs are external disturbances, in certified safe
controller synthesis approaches are frequently violated in operational deployment under …

[HTML][HTML] Analogues ultra-rapides de l'insuline et délivrance automatisée de l'insuline, un réel pas en avant?

L Meyer - Médecine des Maladies Métaboliques, 2024 - Elsevier
Résumé Ces dernières années, plusieurs analogues ultra-rapides de l'insuline ont été
développés afin de réduire la durée d'absorption sous-cutanée de l'insuline et améliorer …

New insulins, biosimilars, and insulin therapy

T Danne, L Heinemann, J Bolinder - Diabetes Technology & …, 2022 - liebertpub.com
Background Insulin icodec is a novel basal insulin analog intended for once‐weekly
administration. The aim of this phase 2 trial was to investigate the efficacy and safety of …

СИБИРСКИЙ МЕДИЦИНСКИЙ ВЕСТНИК

ИА ДУДИНА, МВ БОНДАРЬ - … МЕДИЦИНСКИЙ ВЕСТНИК Учредители …, 2022 - elibrary.ru
Высокая вариабельность гликемии (ВГ) оказывает значительное влияние на
прогрессирование осложнений у больных сахарным диабетом (СД). В ходе работы при …